COMP <GO>
RPRX vs GMAB // OPERATING MARGIN
Royalty Pharma plc (Class A) (NASDAQ) VS. Genmab A/S ADS (NASDAQ) • 15-METRIC TALLY: RPRX 4
— GMAB 7
▲ OPERATING MARGIN LEADER: RPRX
LAST: $65.93 (+1.71%) • MKT CAP: $37.91B
operating-margins
65.60%
LAST: $56.49 (-1.40%) • MKT CAP: $35.25B
operating-margins
13.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RPRX VS. GMAB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RPRX | GMAB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.00% | 9.90% | -2.90 | GMAB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 27.8x | 21.0x | +6.80 | GMAB | /valuation <GO> |
| Free Cash Flow Yield | 6.29% | 2.21% | +4.08 | RPRX | /fcf-yield <GO> |
| Operating Margin ACTIVE | 65.60% | 13.90% | +51.70 | RPRX | /operating-margins <GO> |
| Net Profit Margin | 32.40% | 10.90% | +21.50 | RPRX | /net-margins <GO> |
| Revenue Growth (YoY) | 5.10% | 22.00% | -16.90 | GMAB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.90 | 3.74 | -0.84 | GMAB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.6 | 85.2 | -16.60 | GMAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 1.09 | -0.15 | GMAB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 45.8x | 27.6x | +18.20 | GMAB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $37.91B | $35.25B | $2.66B | RPRX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RPRX REV | GMAB REV | RPRX GROSS % | GMAB GROSS % | RPRX FCF | GMAB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.38B | — | — | — | $2.38B | — |
| FY 2024 | $2.26B | — | — | — | $2.67B | — |
| FY 2023 | $2.35B | — | — | — | $2.88B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RPRX // BETA 0.94
GMAB // BETA 1.09